Do not use in pregnant or lactating bitches.

Following the first vaccination, up to 80% of puppies develop a small visible swelling (<2cm) lasting for generally only two days. Following the second vaccination, occasionally a small visible swelling (up to 5 cm) may be seen at the injection site, which may last for up to five days. The swelling may be painful for 1-2 days. In most cases these small and transient injection site reactions resolve with no need for treatment.

Syringes and needles should not have been sterilised chemically or be above ambient temperature. Do not use chemicals to disinfect or sterilise skin.

Reconstituted vaccine should be used immediately.

Shake well before use.

Avoid the introduction of contamination during use.

Sterile needles and syringes should be used for administration.

Aseptic precautions should be observed.

Only healthy dogs should be vaccinated.

The vaccine may not be effective in dogs incubating the disease at the time of vaccination.

The efficacy of CDV and CPV components of the vaccine may be reduced due to maternal antibody interference. However, the vaccine has been proved to be of benefit against virulent challenge in the presence of maternal antibody levels to CDV and CPV that are likely to be encountered under field conditions.

In situations where higher MDA levels are expected the vaccination protocol should be planned accordingly.

Withdrawal period: Not applicable.

In the event of an allergic or anaphylactic reaction, immediate treatment should be given with a soluble glucocorticoid intravenously (e.g. dexamethasone sodium phosphate).

No information is available on the effects of the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccine should be administered within 14 days before or after vaccination with this product.

Animals that have received the corresponding antiserum or immunosuppressive drugs (e.g. glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed.